Zobrazeno 1 - 4
of 4
pro vyhledávání: '"C. El Hannani"'
Autor:
Sylvie Van Hulst, Jerome Martin-Babau, Olivier Dupuis, Roger Faroux, Laurent Miglianico, Jean-Philippe Metges, Marc Porneuf, Claire Stampfli, Veronique Jestin Le Tallec, C. El Hannani, Philippe Deguiral, James Bassoulet, Christian Riche, Jean-Yves Douillard, Fanny Marhuenda, A. Gourlaouen, Jean-Luc Raoul, Delphine Deniel Lagadec, F. Grude, Jean François Ramée
Publikováno v:
Journal of Clinical Oncology. 33:714-714
714 Background: Metastatic Colorectal Cancer (mCRC) often occurs in patients older than 70 years old. Monoclonal antibodies targeting EGFR have improved the outcome of mCRC patients. Panitumumab in monotherapy is indicated in wild-type K-RAS mCRC pro
Autor:
C. El Hannani, J.-Y. Douillard, E. Francois, Roger Faroux, Jean-Louis Formento, M. Etienne-Grimaldi, J.H. Jacob, J. Bennouna, Gérard Milano, Mireille Francoual
Publikováno v:
Journal of Clinical Oncology. 27:4069-4069
4069 Background: Our purpose was to test the predictive value of germinal gene polymorphisms potentially linked to cetuximab, fluoropyrimidine and irinotecan pharmacodynamics on toxicity, clinical response, time to progression (TTP) and overall survi
Autor:
Hervé Perrier, J. Bennouna, Roger Faroux, C. El Hannani, C. Ligeza, J.-Y. Douillard, G. Perrocheau, E. Francois, Françoise Desseigne, J.H. Jacob
Publikováno v:
Journal of Clinical Oncology. 25:4087-4087
4087 Background: A phase II study (ASCO 2004) established that the combination of UFT (tegafur-uracil) with LV and irinotecan (TEGAFIRI) could be safely administered to pts with unresectable mCRC, with an objective response rate (ORR) of 34% and a me
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.